Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Harvard Business School
Moodys
McKinsey

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR NICORETTE (MINT)


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Nicorette (mint)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00139516 ↗ Chinese Community Smoking Cessation Project Completed National Heart, Lung, and Blood Institute (NHLBI) N/A 2001-09-01 The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00139516 ↗ Chinese Community Smoking Cessation Project Completed University of California, San Francisco N/A 2001-09-01 The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00158171 ↗ Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 2002-04-01 Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nicorette (mint)

Condition Name

Condition Name for Nicorette (mint)
Intervention Trials
Tobacco Dependence 15
Smoking Cessation 10
Tobacco Use Disorder 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Nicorette (mint)
Intervention Trials
Tobacco Use Disorder 22
Pulmonary Disease, Chronic Obstructive 1
Lung Diseases, Obstructive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Nicorette (mint)

Trials by Country

Trials by Country for Nicorette (mint)
Location Trials
United States 16
Sweden 12
China 4
South Africa 3
Russian Federation 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Nicorette (mint)
Location Trials
Nebraska 2
North Carolina 2
Wisconsin 2
Minnesota 2
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Nicorette (mint)

Clinical Trial Phase

Clinical Trial Phase for Nicorette (mint)
Clinical Trial Phase Trials
Phase 4 7
Phase 2/Phase 3 1
Phase 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Nicorette (mint)
Clinical Trial Phase Trials
Completed 36
Recruiting 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Nicorette (mint)

Sponsor Name

Sponsor Name for Nicorette (mint)
Sponsor Trials
McNeil AB 14
National Institute on Drug Abuse (NIDA) 4
VA Office of Research and Development 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Nicorette (mint)
Sponsor Trials
Industry 29
Other 27
NIH 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
McKesson
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.